Allied Market Research


Brain Tumor Drug Market

Brain Tumor Drug Market Size, Share, Competitive Landscape and Trend Analysis Report by Therapy Type, by Indication and by Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Cancer being a global public health problem is the second leading cause of morbidity in the U.S. The brain tumor drug market is likely to grow due to the incidence of new diseases and the geriatric population around the globe. The brain tumor drug treats the abnormal growth of cells in the brain. Depending on the location, shape, and size, brain tumor drugs are used in combinations or alone. For instance, drugs such as Temozolomide, Avastin, BiCNU carmustine are used in treating brain tumors. Government initiatives, rising awareness about the upcoming therapies are likely to accelerate the market in the coming years.


What is the Impact of COVID-19 Pandemic on the Brain Tumor Drug Market?

  • The impact of COVID-19 has shown staggering and unprecedented, with a positive demand for brain tumor drugs across all regions of the world amid the pandemic. There has been a high demand for drugs in the emergency of the COVID-19. 
  • Supply chain management has been improved by the pharmaceutical companies and thus has enhanced their research and development and rise in investment in their quality control and manufacturing.
  • Many of the key leading players have seen a rise in the brain tumor drugs sales scenario and have observed a rise in the demand during the post-pandemic levels. The market players aim to provide effective options to cure brain tumor treatment globally. Therefore, a large investment is predicted in R&D in the upcoming years.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:
Growth in the number of Neurological Disorders is likely to raise the demand: 
The rapid rise in the number of neurological disorders is seen in children and adults is enhancing the brain tumor drug market growth. Brain disorders, which include an amalgamation of neurogenerative disorders, psychiatric, development are the factors responsible for the increase in the cause of deaths globally, thus largely associated with the relatively high geriatric population. As per the American Medical Association (AMA), globally more than 20% of the population is expected to be aged 65 years and above.

New Growth opportunities to be Generated due to Robust Drug Pipelines. 
Globally, advanced patient care is provided for brain disorders due to advancements in medical treatment. Experiments and innovations leading to combination therapies with existing and new drugs have led to an increase in the number of patients with brain tumor diseases. 

The rise in the use of targeted therapies to act as a restriction in the market. Drugs that target the elimination of cancer cells thus, without harming the normal body cells. For example, Bevacizumab averts the replication of cancer cells, thus cytotoxic chemotherapy drugs that restrict the division of normal cells. Additionally, the rising acceptance of these procedures and therapies are likely to cause hurdles in the use of traditional brain tumor drugs, which may damage the growth of market expansion.

Key Benefits of the Report:

  • This study presents the analytical depiction of the global brain tumor drug market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global brain tumor drug market share.
  • The current market is quantitatively analyzed to highlight the global brain tumor drug market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global brain tumor drug market analysis based on competitive intensity and how the competition will take shape in the coming years. 

Questions Answered in the Brain Tumor Drug Market Research Report:

  • What are the leading market players active in the brain tumor drug market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Brain Tumor Drug Market Report Highlights

Aspects Details
By Therapy Type
  • Targeted Therapy
  • Chemotherapy
  • Immunotherapy
  • Others
By Indication
  • Pituitary Tumors
  • Meningioma
  • Glioblastoma
  • Others
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
By Region
  • North America  (U.S, Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, India, Japan, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players

Bristol-Myers Squibb, Pfizer Inc, Johnson & Johnson, Y-mabs Therapeutics, Inc., Novartis AG, Merck & Co, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Brain Tumor Drug Market

Global Opportunity Analysis and Industry Forecast, 2023-2032